Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leukocyte-rich vs Leukocyte-poor PRP for Knee Cartilage Degeneration
NCT02923700Phase 4Completed
- Sponsor
- Istituto Ortopedico Rizzoli
- Start
- Sep 2016
- Primary completion
- Sep 2017
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of platelet-rich plasma in osteoarthritis (OA) (2 arms), sponsored by Istituto Ortopedico Rizzoli. Primary endpoint: International Knee Documentation Committee Subjective Score at 12 months. Started Sep 2016; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02923700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02923700.